Bakson Drugs And Pharmaceuticals Private Limited, a active private limited company, was established on 17 May 1989 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74899DL1989PTC036300. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹7.50 M and a paid-up capital of ₹7.04 M.
It upholds a compliant status. Employing 137 professional, Its leadership includes Satinder Pal Singh Bakshi (Director), Tanya Bakshi (Director), Tamanna Bakshi (Director). Past directors included Seema Bakshi, Mohinderpalsingh Bakshi, Tanya Bakshi. It holds ₹39.24 Cr open charges and ₹79.60 Cr settled loans. Its latest AGM occurred on 28 September 2024, with the balance sheet filed on 31 March 2024. It is based at A-51 Ndse-I, New Delhi, Delhi, 110049.
U74899DL1989PTC036300
036300
17 May 1989
₹7.50 M
₹7.04 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Bakson Drugs And Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Satinder Pal Singh Bakshi | Director | 17 May 1989 | Current |
| Tanya Bakshi | Director | 17 Oct 2022 | Current |
| Tamanna Bakshi | Director | 17 Oct 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Director | 25 Nov 2020 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Director | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Bakson Drugs And Pharmaceuticals Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 7.68% increase. The company also saw a slight decrease in profitability, with a 4.48% decrease in profit. The company's net worth moved up by a moderate rise of 5.97%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Bakson Drugs And Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹392,400,000.00
₹795,968,885.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Mar 2025 | Others | ₹7.90 Cr | Open |
| 22 Nov 2023 | Axis Bank Limited | ₹1.09 Cr | Open |
| 31 May 2023 | Others | ₹5.25 Cr | Open |
| 15 Oct 2022 | Others | ₹1.00 Cr | Open |
| 19 Sep 2002 | Others | ₹24.00 Cr | Open |
Explore comprehensive loan charge details -
Bakson Drugs And Pharmaceuticals has a workforce of 137 employees as of Mar 13, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Bakson Drugs And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bakson Drugs And Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 79.00 M with Charge ID 101067400 was registered on 24 Mar 2025. was recorded as a recent event.
The activity A charge registered on 28 Oct 2022 via Charge ID 100675676 with Hdfc Bank Limited was fully satisfied on 04 Feb 2025. was completed.
The activity A charge registered on 20 Jul 2021 via Charge ID 100489383 with Axis Bank Limited was fully satisfied on 18 Dec 2024. was completed.
The activity Bakson Drugs And Pharmaceuticals Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records. was completed.
Progress on Bakson Drugs And Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
Progress on A charge with Axis Bank Limited amounted to Rs. 10.90 M with Charge ID 100852119 was registered on 22 Nov 2023. was documented.
The CIN of Bakson Drugs And Pharmaceuticals Private Limited is U74899DL1989PTC036300.
Bakson Drugs And Pharmaceuticals Private Limited is headquartered at A-51 Ndse-I, New Delhi, Delhi, 110049.
Bakson Drugs And Pharmaceuticals Private Limited was incorporated on 17 May 1989.
The current directors of Bakson Drugs And Pharmaceuticals Private Limited are
The primary industry of Bakson Drugs And Pharmaceuticals Private Limited is Manufacturing.
Bakson Drugs And Pharmaceuticals Private Limited is unlisted.
The authorized capital of Bakson Drugs And Pharmaceuticals Private Limited is ₹7.50 M, and the paid-up capital is ₹7.04 M.
The compliance status of Bakson Drugs And Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX